ABOUT
Guangzhou Aoxiang Medical Technology Co., Ltd. was established in May 2024. It is a medical device research and development company with a disruptive innovation spirit, focusing on exploring cutting-edge medical technologies that have the potential to change the current status of disease diagnosis and treatment, in order to help people live healthier and happier lives.
Based on this vision goal, we have formed a professional team that covers the entire process from research and development to commercialization.
At present, Soar Medical is focusing on exploring the clinical application value of non-invasive nerve block technology, an emerging subdivision technology in the field of neural regulation, in some disease areas. It has accumulated several domestically or globally innovative products in male health, female health, ear, nose, throat, chronic pain and other fields. Clinical trial data of some products show that they have outstanding therapeutic effects and have the potential to change the diagnosis and treatment status of this field, bringing new revolutionary treatment methods to patients. Several products are about to enter the commercialization stage.
We are filled with reverence for life, but at the same time, we possess the adventurous spirit of the brave, daring to face the unknown risks of innovative research and development in order to help patients receive better treatment. Our team's professional knowledge and unwavering spirit of exploration will guide us forward!
CORPORATE CULTURE
Innovate
————
Professional
————
Sincerity
————
Excellence
————————
TEAM INTRODUCTION
Professor Deng Chunhua
Chief Scientific Advisor
The core inventor of this project's technology
Renowned expert in the field of male reproductive health in China, with 30 years of clinical and scientific research experience in this field. Specializes in the research of the pathogenesis and new diagnostic and treatment methods of male diseases, as well as the development of new neural electrical stimulation technologies.
Chairman of the Andrology Branch of the Chinese Medical Association, 1st and 2nd Chairperson of the Andrology Branch of the Guangdong Medical Association, and Academician of the Hong Kong Academy of Medical Sciences.
Director of Men's Health Department, Zhongshan First Hospital, Guangzhou
Du Xianglin
Co founder/General Manager
In the past 20 years, with a background in the domestic medical industry, entrepreneurship, and investment, I have served as the General Manager of Rongsheng Investment Company, a subsidiary of the large domestic industrial group Hongxing Erke Investment, responsible for investing in the medical field in the United States and China. The company has invested over 200 million US dollars in the medical field.
In the past 6 years, we have continuously researched and tracked the progress of global neural electrical stimulation research, accumulated a large number of project resources, scientists, and technical experts, and have the resources and capabilities to continuously build product pipelines and operate projects in this field.
Zhou Zhenyu
Co founder/Head of Capital Operations
With over 10 years of investment and merger experience in the medical field, I have worked for Minsheng Securities Medical and SoftBank China, developing market and investment and merger strategies for multiple medical device industry companies.
Leading investment and merger projects: Lianying Medical, Leitai Medical, Outai Medical, Kaishitong Semiconductor, etc,
I have rich experience and a deep network of contacts in medical project capital operation and business expansion.